AT&T reported a 21 percent decline in third-quarter profit, hurt by merger costs and other expenses that offset a near 3 percent climb in revenue, with results coming in short of Wall Street estimates. The telecommunications company slashed its revenue guidance for the full year, citing lesser-than-expected subscriber additions for its no-contract Next wireless plans.
Enterprise software maker Citrix Systems Inc. (CTXS), Wednesday reported a drop in profit for the third quarter, hurt largely by a charge related to a patent lawsuit even as revenues grew 6 percent. Earnings for the quarter came in ahead of Wall Street estimates, but revenues fell short of expectations.
Information technology management software maker CA Technologies, Inc. (CA) said Wednesday that its second quarter profit rose 7.7% from last year, as better cost control and an income tax benefit more than offset a slight decrease in revenue.
The company's quarterly earnings per share, excluding...
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory.
U.S. crude oil plummeted to end sharply lower on Wednesday, after a weekly oil report from the U.S. Energy Information Administration showed crude oil inventories to have surged nearly three times more than expected last week, with renewed concerns over excess supply globally.
Earlier today, a weekly...
Stocks have turned lower over the course of the trading day on Wednesday after moving modestly higher earlier in the session. The major averages have pulled back well off their highs for the session and into negative territory.
Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday.
Gold futures snapped a two-day gain to end lower on Wednesday, as the dollar trended higher against a select band of currencies after some encouraging data from the U.S. showed inflation to have risen marginally in September, even as investors anticipate a fresh round of stimulus from the European Central...
After initially showing a lack of direction, stocks have moved modestly higher over the course of the trading day on Wednesday. Buying interest has remained relatively subdued, however, limiting the upside for the markets.
Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
Stocks are turning in a lackluster performance in early trading on Wednesday after moving sharply higher over the past few sessions. The major averages have been bouncing back and forth across the unchanged line, unable to sustain any significant moves.
Diversified financial services provider U.S. Bancorp Wednesday reported a rise in the third-quarter profit, reflecting higher total net revenue, driven by increase in both net interest income and fee-based revenue. Earnings per share, as well as revenues matched analysts' expectations. Provision for credit losses slightly increased from last year.
Global biotechnology firm Biogen Idec, Inc. reported Wednesday a profit for the third quarter that surged 76 percent from last year, reflecting lower charges and strong double-digit revenue growth amid improved sales of multiple sclerosis drugs Tysabri and Tecfidera. Both adjusted earnings per share and quarterly revenues topped analysts' expectations
Consumer prices in the U.S. unexpectedly showed a modest increase in the month of September, according to a report released by the Labor Department on Wednesday, with higher prices for food and shelter offsetting a continued decline in energy prices.
Medical device maker Boston Scientific Corp. on Wednesday reported a turnaround to profit in the third quarter reflecting higher sales in the cardiovascular and rhythm management segments. Looking ahead, the company provided financial outlook for the fourth quarter in line with Street view. For fiscal 2014, the company raised the lower end of its adjusted earnings forecast.